Amneal is voluntarily recalling four lots of Vancomycin Hydrochloride for Oral Solution, 250 mg/5 mL packaged in 80 mL, 150 mL or 300 mL pack sizes, to the consumer level. Some bottles may have ...

Oral Vancomycin Solution Kit Launched CutisPharma announced the launch of FIRST Vancomycin oral solution compounding kits for the treatment of Clostridium difficile (C.diff) infection. CutisPharma ...

CutisPharma announced the availability of Firvanq (vancomycin HCl) for oral solution to treat Clostridium difficile-associated diarrhea and enterocolitis caused by Staphylococcus aureus ...

Our launch of Vancomycin for Oral Solution addresses an unmet need in the treatment of staph and C-diff infections and provides patients, physicians and pharmacists with a convenient, FDA-approved ...

Amneal Pharmaceuticals, LLC. Bridgewater, New Jersey (Amneal), is voluntarily recalling 4 lots (see table below) of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL packaged in 80 mL ...

WILMINGTON — CutisPharma announced that the US Food and Drug Administration has approved FIRVANQ (vancomycin hydrochloride) for oral solution for the treatment of Clostridium difficile ...

Wilmington, MA, Azurity Pharmaceuticals, Inc. (“Azurity”) is voluntarily recalling one lot of Firvanq® (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit (“Firvanq ...

Clinical response was noted in 47.6% of patients treated with oral vancomycin therapy for IBD associated with PSC. Vancomycin-resistant enterococci was reported in 8.7% of patients following ...

WILMINGTON, Mass., April 2, 2018 /PRNewswire/ -- CutisPharma announced today the commercial launch of FIRVANQ™ (vancomycin hydrochloride) for oral solution, for the treatment of Clostridium ...

In order to assist patients and prescribers with dosing flexibility, ANI will commercialize Vancomycin for Oral Solution, now with a mixed berry flavor, in three packaging configurations – 80 mL ...